Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Contango Ore Q2 EPS $(2.10) May Not Compare To $(0.91) Estimate

Contango Ore (AMEX:CTGO) reported quarterly losses of $(2.10) per share which missed the analyst consensus estimate of $(0.91) by 130.77 percent. This is a 191.67 percent decrease over losses of $(0.72) per share from
byMichael Horton
February 6, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Contango Ore (AMEX:CTGO) reported quarterly losses of $(2.10) per share which missed the analyst consensus estimate of $(0.91) by 130.77 percent. This is a 191.67 percent decrease over losses of $(0.72) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Adamis Announces Review Of Strategic Alternatives; May Include Partnership Or Sale Of One Or Both Of The Company’s Commercial Products Symjepi® And Zimhi®, A Merger, Sale, Or Reverse Merger Of The Company, And/or Seeking Additional Financing

By Benzinga Newsdesk
October 3, 4:33 PM
SAN DIEGO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a specialty biopharmaceutical company primarily focused on developing and commercializing products in various

ADMP